Our resources for your clinical practice
Global Reach: Trusted by 12,000+ HCPs across 40+ countries annually.
Expert-Endorsed: Backed by EASL, APASL, GLI, and FIP (coming soon).
Real-World Insights: relevant educational content powered by clinical data.
Actionable Tools: From articles to expert-led videos and presentations.
Trend Authority: Curated by global scientific leaders.
Multidisciplinary Hub: The only global platform connecting liver health experts with practical solutions.
What would be the best therapeutic approach of EPLs as adjunctive treatment for MASLD on top of Standard of Care?
Gastroenterologist
Professor Marek Hartleb
What outcomes matter beyond fatty liver and how MASLD can affect and deteriorate patients' QoL?
Gastroenterologist
Professor Marek Hartleb
How EPLs can perform on top of Standard of Care in QoL relief?
Professor Marek Hartleb
Gastroenterologist
What is you position about EPLs as potential adjunctive treatment for T2DM patients with MASLD?
Gastroenterologist
Professor Marek Hartleb
Could you detail more about CLDQ-MASLD/MASH test and the relevance of it to assess QoL improvements in your patients?
Gastroenterologist
Professor Marek Hartleb
What is metabolic fatty liver? How might our consumers understand it better?
Patient
Professor Marek Hartleb
What are the common risk factors of fatty liver (MASLD)?
Patient
Professor Marek Hartleb
Can you deszcribe the progression of fatty liver (MASLD) if left untreated?
Patient
Professor Marek Hartleb
When does a patient need to be worried about getting themselves checked for fatty liver (MASLD)?
Patient
Professor Marek Hartleb
What would be the best therapeutic approach of EPLs as adjunctive treatment for MASLD on top of Standard of Care?
Gastroenterologist
Professor Assad Dajani
What outcomes matter beyond fatty liver and how MASLD can affect and deteriorate patients' QoL?
Gastroenterologist
Professor Assad Dajani
How EPLs can perform on top of Standard of Care in QoL relief?
Gastroenterologist
Professor Assad Dajani
What is you position about EPLs as potential adjunctive treatment for T2DM patients with MASLD?
Gastroenterologist
Professor Assad Dajani
Could you detail more about CLDQ-MASLD/MASH test and the relevance of it to assess QoL improvements in your patients?
Gastroenterologist
Professor Assad Dajani
What is metabolic fatty liver? How might our consumers understand it better?
Patient
Professor Assad Dajani
Can you deszcribe the progression of fatty liver (MASLD) if left untreated?
Patient
Professor Assad Dajani
When does a patient need to be worried about getting themselves checked for fatty liver (MASLD)?
Patient
Professor Assad Dajani
What would be the best therapeutic approach of EPLs as adjunctive treatment for MASLD on top of Standard of Care?
Gastroenterologist
Professor Norbert Stefan
What outcomes matter beyond fatty liver and how MASLD can affect and deteriorate patients' QoL?
Gastroenterologist
Professor Norbert Stefan
How EPLs can perform on top of Standard of Care in QoL relief?
Gastroenterologist
Professor Norbert Stefan
What is you position about EPLs as potential adjunctive treatment for T2DM patients with MASLD?
Gastroenterologist
Professor Norbert Stefan
Could you detail more about CLDQ-MASLD/MASH test and the relevance of it to assess QoL improvements in your patients?
Gastroenterologist
Professor Norbert Stefan
What is metabolic fatty liver? How might our consumers understand it better?
Patient
Professor Norbert Stefan
What are the common risk factors of fatty liver (MASLD)?
Patient
Professor Norbert Stefan
Can you deszcribe the progression of fatty liver (MASLD) if left untreated?
Patient
Professor Norbert Stefan
When does a patient need to be worried about getting themselves checked for fatty liver (MASLD)?
Patient
Professor Norbert Stefan
